Overview
Lata Aluri is a Hematologist and an Oncologist in Gilbert, Arizona. Dr. Aluri is rated as an Experienced provider by MediFind in the treatment of Hemochromatosis. Her top areas of expertise are Paget Disease of the Breast, Essential Thrombocythemia, Familial Colorectal Cancer, and Inflammatory Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3530 S Val Vista Dr, Ste C204, Gilbert, AZ 85297
Honorhealth Ambulatory
John Bibb is an Oncologist and a Hematologist Oncology provider in Phoenix, Arizona. Dr. Bibb is rated as a Distinguished provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Hemochromatosis, and Pleuropulmonary Blastoma. Dr. Bibb is currently accepting new patients.
Ironwood Physicians, PC
Joining Ironwood Cancer & Research Centers in 2004, Dr. Shtivelband received his medical degree and PhD in Experimental Hematology in Russia. After Internal Medicine Residency, Dr. Shtivelband received fellowship training in Hematology and Medical Oncology at MD Anderson Cancer Center in Houston, where he stayed for an additional year to participate in experimental research. Treating patients with all kinds of malignancies and benign hematological problems, Dr. Shtivelband has particular interest in developing research programs to bring the newest advances in the field of Oncology and Hematology to our community. Dr. Shtivelband also heads the Ironwood Cancer & Research Center's research program. He is Board Certified in Internal Medicine, Hematology and Medical Oncology. Dr. Shtivelband is rated as a Distinguished provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Hemochromatosis, Non-Small Cell Lung Cancer (NSCLC), Plasmacytoma, and Lung Cancer.
Ironwood Physicians, PC
Kalyan Mantripragada is a Hematologist in Gilbert, Arizona. Dr. Mantripragada is rated as a Distinguished provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Pulmonary Embolism, Hemochromatosis, Agranulocytosis, Childhood Iron Deficiency Anemia, and Gallbladder Removal.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Mountain SicknessDr. Aluri isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Aluri isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult T-Cell LeukemiaDr. Aluri isExperienced. Learn about Adult T-Cell Leukemia.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Aluri isExperienced. Learn about Anemia.
- AngiosarcomaDr. Aluri isExperienced. Learn about Angiosarcoma.